United States· US:70244-033_4f98e817-83be-84c5-e063-6294a90ada18
Ciprofloxacin and dexamethasone
A medicinal product containing ciprofloxacin hydrochloride; dexamethasone, registered in United States by Sentiss Pharmaceuticals LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE
- Manufacturer
- Sentiss Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170244033011 BOTTLE, DROPPER in 1 CARTON (70244-033-01) / 7.5 mL in 1 BOTTLE, DROPPER
- ndc1170244-033-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/25960c3d-a97e-4861-b999-659a54e82cbb GET /v1/drugs/25960c3d-a97e-4861-b999-659a54e82cbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "AURICULAR (OTIC)",
"source": "ndc",
"strength": "3; 1",
"substance": "CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE",
"productndc": "70244-033",
"dosage_form": "SUSPENSION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "ANDA215768",
"marketing_category": "ANDA"
}See everything about ciprofloxacin hydrochloride; dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.